Literature DB >> 26298380

Sex differences in clinical characteristics and inpatient outcomes among 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Project.

Qinmei Xiong1, Alena Shantsila2, Deirdre A Lane2, Qiongqiong Zhou3, Ying Liu3, Yang Shen3, Xiaoshu Cheng3, Kui Hong3, Gregory Y H Lip4.   

Abstract

BACKGROUND: Limited data exists on the impact of sex on clinical characteristics and outcomes among nonvalvular AF patients from China. We investigated the impact of gender on risk factors and inpatient mortality in a hospitalized nonvalvular AF cohort in Nanchang, China.
METHODS: We studied consecutive patients hospitalized with nonvalvular AF between May 2011 and December 2013. Predictors of inpatient mortality were evaluated using multivariate regression analyses.
RESULTS: We studied 2442 patients (43.7% female; mean age 71.8), with a median hospital stay of 10 days (IQR: 7-14). Inpatient mortality was 2.2%. Mean age, CHADS2 and CHA2DS2-VASc scores were higher in females vs. males (all p<0.0001). Oral anticoagulation use during hospitalization was 33.3% without sex differences, and length of stay and inpatient outcomes were comparable between sexes. On multivariate analyses, the significant risk factors of inpatient death in females were previous ischemic stroke/transient ischemic attack (TIA)/thromboembolism (TE) (Odds Ratio (OR): 2.27; 95% Confidence Intervals (CI): 1.43-3.61), peripheral artery disease (OR: 5.75, 95% CI: 1.49-22.16) and chronic renal disease (OR: 5.68, 95% CI: 1.46-22.13). Among males, only age (OR: 1.06, 95% CI: 1.02-1.11) and previous ischemic stroke/TIA/TE (OR: 1.81, 95% CI: 1.25-2.63) were independent predictors of inpatient mortality.
CONCLUSION: Sex related differences in clinical characteristics and stroke risk profile were evident in Chinese nonvalvular AF patients, but no sex disparity was evident in the low antithrombotic therapy use or inpatient mortality. Previous ischemic stroke/TIA/TE was an important predictor of inpatient mortality in both female and male patients.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Inpatient mortality; Oral anticoagulation; Sex

Mesh:

Year:  2015        PMID: 26298380     DOI: 10.1016/j.ijcard.2015.08.076

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

1.  BMI differences among in-hospital management and outcomes in patients with atrial fibrillation: findings from the Care for Cardiovascular Disease project in China.

Authors:  Fuxue Deng; Yan Zhang; Qiang Zhao; Yangyang Deng; Shanshan Gao; Lisha Zhang; Mengya Dong; Zuyi Yuan; Xinjun Lei
Journal:  BMC Cardiovasc Disord       Date:  2020-06-05       Impact factor: 2.298

2.  Rationale and design of the improving Care for Cardiovascular Disease in China (CCC) project: a national registry to improve management of atrial fibrillation.

Authors:  Yongchen Hao; Jing Liu; Sidney C Smith; Yong Huo; Gregg C Fonarow; Junbo Ge; Jun Liu; Kathryn A Taubert; Louise Morgan; Yang Guo; Mengge Zhou; Dong Zhao; Changsheng Ma
Journal:  BMJ Open       Date:  2018-07-05       Impact factor: 2.692

3.  Mortality and causes of death in patients with atrial fibrillation: A nationwide population-based study.

Authors:  Euijae Lee; Eue-Keun Choi; Kyung-Do Han; HyunJung Lee; Won-Seok Choe; So-Ryoung Lee; Myung-Jin Cha; Woo-Hyun Lim; Yong-Jin Kim; Seil Oh
Journal:  PLoS One       Date:  2018-12-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.